AlphaYou
Overview
Smart money at a glance
Filings to Oct 5, 2026Net buying: insiders sold $0 and bought $82K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- +$82K netNet buying
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 4- Open
- $2.08
- 52-wk high
- $12.37
- High
- $2.13
- 52-wk low
- $1.81
- Low
- $2.05
- Prev close
- $2.07
- Mkt cap
- $16.9M
- Volume
- 38.9K
- Fwd P/E
- 5.6x
- Beta
- 0.47
- P/S
- 10.8x
- P/B
- 0.8x
- Profit margin
- +0.0%
- Op margin
- -1495.0%
- ROE
- -60.9%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about LPCN filings
Are insiders buying or selling Lipocine Inc (LPCN) stock?
Net buying: insiders sold $0 and bought $82K of LPCN stock on the open market in the 90 days to Oct 5, 2026, according to SEC Form 4 filings. The largest was Higuchi, John W. (Director), who bought $82K. The latest filing was on Oct 2, 2026.
Which members of Congress have traded LPCN recently?
None. No member of Congress disclosed a LPCN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this LPCN smart-money data?
This summary uses filings available on Oct 5, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net buying.
What insiders are doing
Buys (2)
- HJ
Higuchi John W.
$55K
bought
- HJ
Higuchi John W.
$27K
bought
How top traders are positioned
No tracked top-trader positions in LPCN right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 31.9% above what analysts expected.
Last report
Aug 4, 2026
Period ending
Jun 30, 2026
Earnings per share
-$0.47 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 4, 2026 | -$0.32 / -$0.47Alpha Vantage | +31.91% beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 7, 2026 | -$0.54 / -$0.48Alpha Vantage | -12.50% miss | Unavailable | Unavailable |
| Dec 31, 2025 | Mar 9, 2026 | -$0.42 / -$0.61Alpha Vantage | +31.15% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | -$0.59 / -$0.54Alpha Vantage | -9.26% miss | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 5, 2025 | -$0.41 / -$0.40Alpha Vantage | -2.50% miss | Unavailable | Unavailable |
| Mar 31, 2025 | May 8, 2025 | -$0.35 / -$0.35Alpha Vantage | +0.00% in line | Unavailable | Unavailable |
| Dec 31, 2024 | Mar 13, 2025 | $0.33 / -$0.40Alpha Vantage | +$0.73 beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 7, 2024 | -$0.44 / -$0.48Alpha Vantage | +8.33% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 5, 2026, in 31 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $114.6K | $1.1M | $119.4K | $190.1K |
| Cost of what it sold | — | $15.0K | $14.8K | $2.0M |
| Gross profit | $114.6K | $1.1M | $104.6K | $190.1K |
| What it spent | ||||
| Research and development | $2.7M | $2.7M | $2.7M | $2.0M |
| Sales and admin | $767.8K | $983.4K | $1.2M | $991.0K |
| Total operating expenses | $3.5M | $3.6M | $4.0M | $3.0M |
| What was left | ||||
| Operating profit | -$3.4M | -$2.5M | -$3.8M | -$2.8M |
| Profit before tax | -$3.2M | -$2.4M | -$3.7M | -$2.6M |
| Tax | — | -$400 | — | $200 |
| Net profit | -$3.2M | -$2.4M | -$3.7M | -$2.6M |
| EBITDA | -$3.2M | -$2.4M | -$3.7M | -$2.6M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace